Acute exacerbations of interstitial lung diseases: Focus on biomarkers
F Drakopanagiotakis, P Markart… - International Journal of …, 2023 - mdpi.com
Interstitial lung diseases (ILDs) are a large group of pulmonary disorders characterized
histologically by the cardinal involvement of the pulmonary interstitium. The prototype of …
histologically by the cardinal involvement of the pulmonary interstitium. The prototype of …
Biomarkers of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
L Guo, J Wang, J Li, J Yao, H Zhao - Frontiers in Immunology, 2024 - frontiersin.org
Background Interstitial Lung Disease (ILD) represents the most common extra-articular
manifestation of Rheumatoid Arthritis (RA) and is a major cause of mortality. This study aims …
manifestation of Rheumatoid Arthritis (RA) and is a major cause of mortality. This study aims …
Non-contrast computed tomography-based radiomics for staging of connective tissue disease-associated interstitial lung disease
S Qin, B Jiao, B Kang, H Li, H Liu, C Ji, S Yang… - Frontiers in …, 2023 - frontiersin.org
Rationale and introduction It is of significance to assess the severity and predict the mortality
of patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). In …
of patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). In …
A computed tomography-based radiomics nomogram for predicting overall survival in patients with connective tissue disease-associated interstitial lung disease
S Qin, B Kang, H Liu, C Ji, H Li, J Zhang… - European Journal of …, 2023 - Elsevier
Objectives Accurate prognostic prediction is beneficial for the management of patients with
connective tissue disease-associated interstitial lung disease (CTD-ILD). The purpose of the …
connective tissue disease-associated interstitial lung disease (CTD-ILD). The purpose of the …
A nomogram model combining computed tomography-based radiomics and Krebs von den Lungen-6 for identifying low-risk rheumatoid arthritis-associated interstitial …
N Han, Z Guo, D Zhu, Y Zhang, Y Qin, G Li… - Frontiers in …, 2024 - frontiersin.org
Objectives Quantitatively assess the severity and predict the mortality of interstitial lung
disease (ILD) associated with Rheumatoid arthritis (RA) was a challenge for clinicians. This …
disease (ILD) associated with Rheumatoid arthritis (RA) was a challenge for clinicians. This …
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection
I Ferrigno, L Verzellesi, M Ottone, M Bonacini… - Inflammation …, 2024 - Springer
Objective and design We aimed to identify cytokines whose concentrations are related to
lung damage, radiomic features, and clinical outcomes in COVID-19 patients. Material or …
lung damage, radiomic features, and clinical outcomes in COVID-19 patients. Material or …
[HTML][HTML] Radiomics on slice-reduced versus full-chest computed tomography for diagnosis and staging of interstitial lung disease in systemic sclerosis: A comparative …
AA Joye, M Bogowicz, J Gote-Schniering… - European Journal of …, 2024 - Elsevier
Purpose The purpose of this study was to evaluate the efficacy of radiomics derived from
slice-reduced CT (srCT) scans versus full-chest CT (fcCT) for diagnosing and staging of …
slice-reduced CT (srCT) scans versus full-chest CT (fcCT) for diagnosing and staging of …
Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case Report
Y Nishii, M Okamoto, Y Zaizen, T Kojima, T Nouno… - Medicina, 2023 - mdpi.com
Insufficient evidence exists regarding the efficacy of Janus kinase inhibitors (JAKis), a class
of targeted synthetic disease-modifying anti-rheumatic drugs (tsDMARDs), in the treatment …
of targeted synthetic disease-modifying anti-rheumatic drugs (tsDMARDs), in the treatment …
The metaverse: a new frontier for rheumatology
JE Liebowitz - Rheumatology, 2024 - academic.oup.com
On 28 October 2021, the company Facebook formally changed its name to Meta. At the time
of the name change, Mark Zuckerberg, the CEO of Meta, stated,'Today we are seen as a …
of the name change, Mark Zuckerberg, the CEO of Meta, stated,'Today we are seen as a …
Advancing Rheumatology Care Through Machine Learning
T Hügle - Pharmaceutical Medicine, 2024 - Springer
Rheumatologic diseases are marked by their complexity, involving immune-, metabolic-and
mechanically mediated processes which can affect different organ systems. Despite a …
mechanically mediated processes which can affect different organ systems. Despite a …